GRI Bio Inc

GRI USD0.0001
Create an alert
Sell$1.80
Buy$1.85
$0.25 (11.36%)
Last updated today at 03:51 UTC

Key metrics

Open$2.06
Previous close$2.20
Market cap$3.01m
P/E ratio-
Volume415,378
Dividend yield0.00%
EMS-

GRI Bio, Inc. is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. The Company’s therapies are designed to target the ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue1.77m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.